ADVFN US – Market Content Editor

Snail Games is increasing its presence in Latin America as the company looks to expand publishing partnerships and capitalize on growing engagement in one of the world’s fastest-growing gaming markets. Key Investor Takeaways Why Snail Stock Is in Focus Snail Games announced that it attended Gamescom LATAM as part of its effort to expand operations,…

Ondas raised its 2026 revenue outlook to at least $390 million as acquisitions, defense demand, and counter-drone contracts rapidly expanded the company’s backlog and operating platform. Key Investor Takeaways Why Ondas Stock Is in Focus Ondas reported first-quarter 2026 revenue of $50.1 million, up from $4.3 million in the same period last year. The company…

AIRO reiterated its full-year revenue growth forecast as the company expands its AI-enabled drone portfolio and builds a defense backlog exceeding $150 million. Key Investor Takeaways Why AIRO Stock Is in Focus AIRO reported first-quarter 2026 revenue of $8.9 million, down from $11.8 million in the same period last year. Gross profit declined to $2.4…

Innoviz reaffirmed its 2026 outlook while highlighting new defense and autonomous driving opportunities, even as first-quarter revenue fell sharply year over year. Key Investor Takeaways Why Innoviz Stock Is in Focus Innoviz reported first-quarter 2026 revenue of $7.1 million, down from $17.4 million in the same period last year. The company attributed the decline partly…

A new $15 million government task order expands OSI Systems’ security backlog and reinforces demand for its cargo and vehicle inspection technologies. Key Investor Takeaways Why OSI Systems Stock Is in Focus OSI Systems announced that its Security division received a task order worth approximately $15 million from a U.S. government customer. Under the agreement,…

Regenxbio (NASDAQ:RGNX) shares gained more than 4% in premarket trading Thursday after investors focused on encouraging clinical trial results for the company’s Duchenne muscular dystrophy therapy, despite weaker-than-expected quarterly financial results. Earnings and Revenue Miss Expectations Regenxbio reported a first-quarter loss of $1.72 per share, wider than analyst expectations of a $1.34 loss per share.…

Biogen (NASDAQ:BIIB) shares jumped 10% on Thursday after the company released encouraging Phase 2 data for diranersen, its experimental Alzheimer’s treatment targeting tau protein accumulation. The results came from the company’s CELIA study, which evaluated the therapy in patients with early-stage Alzheimer’s disease. Trial Shows Reductions in Tau Pathology Biogen said diranersen produced significant reductions…

Intuitive Machines (NASDAQ:LUNR) shares fell more than 3% in premarket trading Thursday after the company reported first-quarter revenue below Wall Street expectations, despite posting strong year-on-year growth and record operational metrics. Revenue Misses Forecasts as Loss Widens The company reported first-quarter revenue of $186.7 million, missing analyst expectations of $200.12 million. Revenue nevertheless nearly tripled…

CorMedix Therapeutics (NASDAQ:CRMD) shares surged 8% in premarket trading Thursday after the company raised its full-year outlook despite reporting quarterly earnings slightly below analyst expectations. Revenue Surges More Than 200% Year-on-Year CorMedix posted adjusted earnings per share of $0.43 for the first quarter, narrowly missing analyst expectations of $0.45 by $0.02. Revenue reached $127.4 million,…

Klarna Group (NYSE:KLAR) shares jumped more than 13% in premarket trading Thursday after the company reported first-quarter results that exceeded Wall Street expectations, supported by strong transaction growth and improving profitability. Revenue and GMV Growth Outpace Expectations Klarna posted an adjusted loss of -$0.01 per share for the quarter, significantly better than analyst forecasts for…